MAQC Society Webinar series

We are happy to share information on the new MAQC-society Webinar Series. These presentations are from science and bioinformatic leaders as they discuss findings and results in cancer genomics and related areas: variant detection of all types (SNVs, Indels, structural variants, CNVs and CNAs), information on new reference materials to test and validate bioinformatic processes, including matched tumor-normal pairs and admixtures of cell lines, evaluation and comparison of cancer panels and liquid biopsy assays, reproducible scRNA-seq methods, and other exciting areas such as epigenomics. These presentations are associated with new research currently being published in Nature Biotechnology, Genome Biology, Cell Genomics, and other journals.

The first four webinars are free to all (after that for MAQC Society members only) and begin on Tuesday 16 February 2021 and will go every Tuesday from 16 February to 20 April 2021 at 17.00 CET leading up to the 4th annual meeting of the MAQC Society (26-28 April 2021).

You can register for the webinars here and see more information here.

Sessions

• 16 February
  A MAQC/SEQC Journey Towards Reproducible Genomics and the MAQC Society
  Weida Tong, PhD
  President, MCBIOS, and Director, Division of Bioinformatics and Biostatistics, FDA-NCTR
  Wendell Jones, PhD
  Executive Chair and President, MAQC Society, and Principle Bioinformaticist and Scientific Advisor, Q² Solutions / EA Genomics

 

• 23 February
  Towards best practice in cancer mutation detection with whole-genome and whole-exome sequencing
  Dr. Wenming Xiao
  Senior Scientific Reviewer, Division of Molecular Genetics and Pathology, FDA-OIR

 

• 2 March
  Establishing reference data and call sets for benchmarking cancer mutation detection using whole-genome sequencing
  Li Tai Fang, PhD
  Staff Scientist, Endpoint Health, Inc.

 

• 9 March
  A multicenter study benchmarking single-cell RNA sequencing technologies using reference samples
  Charles Wang, MD, PhD, MPH
  Professor and Director of Center for Genomics, Loma Linda University School of Medicine

 

• 16 March
  Critical Assessment of Copy Number Variation Calling Using Next Generation Sequencing
  Mehdi Pirooznia , MD, MSc, PhD
  Director of Bioinformatics and Computational Biology Core, NHLBI

 

• 23 March
  A Verified Genomic Reference Sample for Assessing Performance of Cancer Panels Detecting Small Variants of Low Allele Frequency
  Wendell Jones, PhD
  Principal Bioinformaticist and Scientific Advisor, Q² Solutions / EA Genomics
  Executive Chair and President, MAQC Society

 

• 30 March
  Multi-lab cross-oncopanel study reveals high sensitivity and reproducibility tailored to targeted regions and allele frequency ranges
  Binsheng Gong, PhD
  Staff Fellow, Division of Bioinformatics and Biostatistics, FDA-NCTR

 

• 6 April
  Evaluating the analytical validity of circulating tumor DNA sequencing for precision oncology
  Joshua Xu, PhD
  Branch Chief for Research-to-Review — Division of Bioinformatics and Biostatistics, FDA-NCTR
  Executive Secretary, MAQC Society

 

• 7 April
  Robust Cancer Mutation Detection with Deep Learning Models Derived from Tumor-Normal Sequencing Data
  Mohammad Sahraeian, PhD
  Senior Bioinformatics Scientist, Roche Sequencing Solutions

 

• 13 April
  The Epigenome Quality Control (EpiQC) Project
  Christopher Mason, PhD
  Associate Professor; Director, WorldQuant Initiative for Quantitative Prediction Physiology and Biophysics/Feil Family Brain and Mind Institute/Institute for Computational Biomedicine, Weill Cornell Medicine

 

• 14 April
  Multi-Platform Assessment of DNA Sequencing Performance using Human and Bacterial Reference Genomes in the ABRF Next-Generation Sequencing Study
  Jonathan Foox, PhD
  Research Associate in Computational Biomedicine, Weill Cornell Medicine

 

• 20 April
  Assessing Reproducibility of Germline Variants Detected with Short-read Whole Genome Sequencing
  Huixiao Hong, PhD
  Chief, Bioinformatics Branch, FDA-NCTR